AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

INTERNATIONAL BIOTECHNOLOGY TST PLC

Report Publication Announcement Nov 4, 2025

5163_rns_2025-11-04_abe6f218-a6bb-4f7a-9298-77ce8f4c6d9c.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 0102G

Intl. Biotechnology Trust PLC

04 November 2025

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

Investor Presentation via Investor Meet Company

International Biotechnology Trust plc is pleased to announce that Ailsa Craig and Marek Poszepczynski will provide a live presentation on the Company's results for the year ended 31 August 2025 via the Investor Meet Company platform on Thursday 6 November 2025 at 11:00 am GMT.

The presentation is open to all existing and potential investors. Questions can be submitted pre-event via your Investor Meet Company dashboard before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet INTERNATIONAL BIOTECHNOLOGY TRUST PLC via:

https://www.investormeetcompany.com/international-biotechnology-trust-plc/register-investor

Investors who already follow INTERNATIONAL BIOTECHNOLOGY TRUST PLC on the Investor Meet Company platform will automatically be invited.

ENDS

Enquiries:

Schroder Investment Management Limited

Charlotte Banks (Press)

Kirsty Preston

Natalia de Sousa (Company Secretary)
020 7658 6000

020 7658 6000
Kaso Legg Communications (Financial PR)

Charles Gorman                       

Henry Taylor

Effie Aye Maung Hider
[email protected]

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRADZMGMLFFGKZM

Talk to a Data Expert

Have a question? We'll get back to you promptly.